Arcturus Therapeutics Holdings Inc. Analysts Are Pretty Bullish On The Stock After Recent Results [Yahoo! Finance News]
Arcturus Therapeutics Holdings Inc. (ARCT)
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arcturusrx.com/investor-relations
Company Research
Source: Yahoo! Finance News
One of the biggest stories of last week was how Arcturus Therapeutics Holdings Inc. NASDAQ:ARCT View our latest analysis for Arcturus Therapeutics Holdings After the latest results, the consensus from Arcturus Therapeutics Holdings's eight analysts is for revenues of US$15.6m in 2020, which would reflect a substantial 25% decline in sales compared to the last year of performance. The statutory loss per share is expected to greatly reduce in the near future, narrowing 27% to US$2.75. Yet prior to the latest earnings, analysts had been forecasting revenues of US$14.5m and losses of US$2.43 per share in 2020. So it's pretty clear analysts have mixed opinions on Arcturus Therapeutics Holdings after the latest results; even though they upped their revenue numbers, it came at the cost of a real cut to per-share earnings expectations. The average analyst price target rose 11% to US$23.75, even though analysts have been updating their forecasts to show higher revenues and higher forecast loss
Show less
Read more
Impact Snapshot
Event Time:
ARCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARCT alerts
High impacting Arcturus Therapeutics Holdings Inc. news events
Weekly update
A roundup of the hottest topics
ARCT
News
- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.MarketBeat
- Arcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
- Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "outperform" rating re-affirmed by analysts at William Blair.MarketBeat
- Arcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developments [Yahoo! Finance]Yahoo! Finance
ARCT
Earnings
- 3/7/24 - Beat
ARCT
Sec Filings
- 4/5/24 - Form 8-K
- 4/5/24 - Form SC
- 3/27/24 - Form 4
- ARCT's page on the SEC website